-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Xuanzhu Bio-B (02575.HK) announced that after a simple medical insurance renewal with China's National Health Insurance Administration (NHS), the innovative drug amneprazole sodium enteric tablets (trade name: Anjiuwei®) will continue to be included in the new “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (2025 National Basic Medical Insurance Drug Catalogue), which will take effect on January 1, 2026.

Zhitongcaijing·12/08/2025 04:25:03
Listen to the news
Zhitong Finance App News, Xuanzhu Bio-B (02575.HK) announced that after a simple medical insurance renewal with China's National Health Insurance Administration (NHS), the innovative drug amneprazole sodium enteric tablets (trade name: Anjiuwei®) will continue to be included in the new “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (2025 National Basic Medical Insurance Drug Catalogue), which will take effect on January 1, 2026.